The abuse liability of the NMDA receptor antagonist-benzodiazepine (tiletamine-zolazepam) combination: evidence from clinical case reports and preclinical studies-Reference-Cited by-同舟云学术

The abuse liability of the NMDA receptor antagonist-benzodiazepine (tiletamine-zolazepam) combination: evidence from clinical case reports and preclinical studies

Published:2016-06-24 Issue:8 Volume:8 Page:760-767
ISSN:1942-7603
Container-title:Drug Testing and Analysis
language:en
Short-container-title:Drug Test. Analysis

Author:

de la Peña June Bryan¹,Cheong Jae Hoon¹

Affiliation:

1. Uimyung Research Institute for Neuroscience; Sahmyook University; 815 Hwarang-ro Nowon-gu Seoul 139-742 Korea

Publisher

Wiley

Subject

Spectroscopy,Pharmaceutical Science,Environmental Chemistry,Analytical Chemistry

Reference61 articles.

1. USFDA Animal drugs at FDA http://www.accessdata.fda.gov/scripts/animaldrugsatfda/details.cfm?dn=106-111

2. A fatality related to the veterinary anesthetic telazol;Cording;J. Anal. Toxicol.,1999

3. Nitric oxide and angiotensin II receptors mediate the pressor effect of angiotensin II: a study in conscious and zoletil-anesthetized rats;Guarda;Anesth. Analg.,2007

4. Comparison of cardiovascular effects of tiletamine-zolazepam, pentobarbital, and ketamine-xylazine in male rats;Saha;J. Am. Assoc. Lab. Anim. Sci.,2007

5. Evaluation of two combinations of Domitor, Zoletil 100, and Euthatal to obtain long-term nonrecovery anesthesia in Sprague-Dawley rats;Ferrari;Comp. Med.,2005

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NMDA receptor within nucleus accumbens shell regulates propofol self‐administration through D1R/ERK/CREB signalling pathway;Addiction Biology;2024-05

2. Rising abuse of veterinary drugs;Nursing;2022-11

3. Arousal and drug abuse;Arousal in Neurological and Psychiatric Diseases;2019

4. Glucocorticoid receptor in rat nucleus accumbens: Its roles in propofol addictions;Neuroscience Letters;2018-01

5. Treatment of Comorbid Alcohol Dependence and Anxiety Disorder: Review of the Scientific Evidence and Recommendations for Treatment;Frontiers in Psychiatry;2017-09-22